Serum Metal Ion Levels in Modular Dual Mobility Hips


About this study

The purpose of this study is to determine if modular dual mobility (MDM) hips are at risk of increased serum metal ion levels.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:     

  • Any living patient with a history of modular dual mobility hip replacement.

Exclusion Criteria:    

  • Any patient who is a child or who we are not able to obtain follow-up information on.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Abdel, M.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer